R. Reilly

The immunoreactivity of radiolabeled antibodies--its impact on tumor targeting and strategies for preservation.

R. Reilly, 2004, Cancer biotherapy & radiopharmaceuticals.

Labelling of monoclonal antibodies 10B, 8C, and M2A with indium-111.

S. Houle, A. Marks, K. Sheldon, 1989, International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes.

Optimum labelling of monoclonal antibody 3El.2 with 111in using a bifunctional chelate

R. Reilly, G. Ege, 1987 .

Monocyte chemotaxis mediated by formyl-methionyl-leucyl-phenylalanine conjugated with monoclonal antibodies against human ovarian carcinoma.

R. Bast, T. Leavitt, R. Knapp, 1983, International journal of immunopharmacology.

Highlight selection of radiochemistry and radiopharmacy developments by editorial board

Y. Seimbille, B. Cornelissen, W. Szymański, 2021, EJNMMI Radiopharmacy and Chemistry.

In vitro stability of EDTA and DTPA immunoconjugates of monoclonal antibody 2G3 labeled with indium-111.

S. Houle, A. Marks, J. Law, 1992, International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes.

Highlight selection of radiochemistry and radiopharmacy developments by editorial board

Y. Seimbille, B. Cornelissen, A. Duatti, 2022, EJNMMI Radiopharmacy and Chemistry.

Intraperitoneal therapy of malignant ascites associated with carcinoma of ovary and breast using radioiodinated monoclonal antibody 2G3

R. Buckman, P. Shaw, Alexander Marks, 1992, Gynecologic oncology.